Quadrant Private Wealth Management, LLC Novavax Inc Transaction History

Quadrant Private Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $105,152 - $215,493	-1,508 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $71,120 - $108,232	-400 Reduced 20.96%	1,508 $313,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $12,100 - $25,767	100 Added 5.53%	1,908 $405,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $60,783 - $172,122	-538 Reduced 22.93%	1,808 $328,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $4,881 - $8,649	-62 Reduced 2.57%	2,346 $262,000
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $13,902 - $31,239	-175 Reduced 6.78%	2,408 $261,000
Q2 2020 Aug 04, 2020	BUY	$13.86 - $83.61 $35,800 - $215,964	2,583 New	2,583 $215,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Quadrant Private Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Private Wealth Management, LLC with notifications on news.